SMCAY Quote, Financials, Valuation and Earnings

Kubota has a net margin of 24.02% compared to SMC's net margin of 6.75%. SMC's return on equity of 9.87% beat Kubota's return on equity of 9.86%.

SMC has a consensus price target of --, signalling downside risk potential of --. On the other hand Kubota has an analysts' consensus of -- which suggests that it could grow by 40.16%. Given that Kubota has higher upside potential than SMC, analysts believe Kubota is more attractive than SMC.

SMC has a beta of 0.802, which suggesting that the stock is 19.808% less volatile than S&P 500. In comparison Kubota has a beta of 0.959, suggesting its less volatile than the S&P 500 by 4.058%.

SMC has a quarterly dividend of $0.17 per share corresponding to a yield of 1.63%. Kubota offers a yield of 2.8% to investors and pays a quarterly dividend of $0.85 per share. SMC pays 32.56% of its earnings as a dividend. Kubota pays out 22.85% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SMC quarterly revenues are $1.3B, which are smaller than Kubota quarterly revenues of $4.7B. SMC's net income of $312.4M is lower than Kubota's net income of $317.2M. Notably, SMC's price-to-earnings ratio is 21.62x while Kubota's PE ratio is 8.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SMC is 4.84x versus 0.68x for Kubota. Usually stocks with elevated PS ratios are considered overvalued.

Kyocera has a net margin of 24.02% compared to SMC's net margin of 7.38%. SMC's return on equity of 9.87% beat Kyocera's return on equity of 3.11%.

SMC has a consensus price target of --, signalling downside risk potential of --. On the other hand Kyocera has an analysts' consensus of -- which suggests that it could grow by 12.64%. Given that Kyocera has higher upside potential than SMC, analysts believe Kyocera is more attractive than SMC.

SMC has a beta of 0.802, which suggesting that the stock is 19.808% less volatile than S&P 500. In comparison Kyocera has a beta of 0.279, suggesting its less volatile than the S&P 500 by 72.095%.

SMC has a quarterly dividend of $0.17 per share corresponding to a yield of 1.63%. Kyocera offers a yield of 3.28% to investors and pays a quarterly dividend of $0.17 per share. SMC pays 32.56% of its earnings as a dividend. Kyocera pays out 73.91% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SMC quarterly revenues are $1.3B, which are smaller than Kyocera quarterly revenues of $3.2B. SMC's net income of $312.4M is higher than Kyocera's net income of $236M. Notably, SMC's price-to-earnings ratio is 21.62x while Kyocera's PE ratio is 20.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SMC is 4.84x versus 1.02x for Kyocera. Usually stocks with elevated PS ratios are considered overvalued.

Nidec has a net margin of 24.02% compared to SMC's net margin of -3.46%. SMC's return on equity of 9.87% beat Nidec's return on equity of 8.22%.

SMC has a consensus price target of --, signalling downside risk potential of --. On the other hand Nidec has an analysts' consensus of -- which suggests that it could grow by 43.68%. Given that Nidec has higher upside potential than SMC, analysts believe Nidec is more attractive than SMC.

SMC has a beta of 0.802, which suggesting that the stock is 19.808% less volatile than S&P 500. In comparison Nidec has a beta of 1.080, suggesting its more volatile than the S&P 500 by 8.006%.

SMC has a quarterly dividend of $0.17 per share corresponding to a yield of 1.63%. Nidec offers a yield of 1.49% to investors and pays a quarterly dividend of $0.03 per share. SMC pays 32.56% of its earnings as a dividend. Nidec pays out 32.08% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

SMC quarterly revenues are $1.3B, which are smaller than Nidec quarterly revenues of $4B. SMC's net income of $312.4M is higher than Nidec's net income of -$138.3M. Notably, SMC's price-to-earnings ratio is 21.62x while Nidec's PE ratio is 27.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SMC is 4.84x versus 1.23x for Nidec. Usually stocks with elevated PS ratios are considered overvalued.

SBC Medical Group Holdings has a net margin of 24.02% compared to SMC's net margin of 5.34%. SMC's return on equity of 9.87% beat SBC Medical Group Holdings's return on equity of 25.89%.

SMC has a consensus price target of --, signalling downside risk potential of --. On the other hand SBC Medical Group Holdings has an analysts' consensus of -- which suggests that it could grow by 77.13%. Given that SBC Medical Group Holdings has higher upside potential than SMC, analysts believe SBC Medical Group Holdings is more attractive than SMC.

SMC has a beta of 0.802, which suggesting that the stock is 19.808% less volatile than S&P 500. In comparison SBC Medical Group Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

SMC has a quarterly dividend of $0.17 per share corresponding to a yield of 1.63%. SBC Medical Group Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SMC pays 32.56% of its earnings as a dividend. SBC Medical Group Holdings pays out -- of its earnings as a dividend. SMC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SMC quarterly revenues are $1.3B, which are larger than SBC Medical Group Holdings quarterly revenues of $53.1M. SMC's net income of $312.4M is higher than SBC Medical Group Holdings's net income of $2.8M. Notably, SMC's price-to-earnings ratio is 21.62x while SBC Medical Group Holdings's PE ratio is 14.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SMC is 4.84x versus 2.86x for SBC Medical Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.